COMMUNIQUÉS West-GlobeNewswire
-
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026
02/07/2026 -
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
02/07/2026 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026
02/07/2026 -
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
02/07/2026 -
GuideAI Health Corp. Engages Market Maker
02/07/2026 -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Spyre Therapeutics Announces Grants of Inducement Awards
02/07/2026 -
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
02/07/2026 -
Profusa Announces 1-for-25 Reverse Stock Split
02/07/2026 -
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
02/07/2026 -
GENFIT annonce l’accès à la couverture et le futur remboursement par Medicare aux États-Unis de NASHnext®, une technologie visant à identifier les patients atteints de MASH « à risque »
02/07/2026 -
Declaration voting rights - June 30,2026
02/07/2026 -
Déclaration droits de vote - 30 juin 2026
02/07/2026 -
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
02/07/2026 -
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
02/07/2026 -
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology
02/07/2026 -
Cannara obtient les droits exclusifs au Canada sur la technologie d’infusion Ampersand™ Live Rosin de Blue River
02/07/2026
Pages